MetLife Investment Management LLC lifted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 7.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 197,219 shares of the company's stock after purchasing an additional 14,311 shares during the quarter. MetLife Investment Management LLC owned 0.12% of Option Care Health worth $4,575,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of OPCH. JPMorgan Chase & Co. increased its holdings in shares of Option Care Health by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after purchasing an additional 344,875 shares during the period. Graypoint LLC acquired a new position in Option Care Health in the 4th quarter valued at $1,161,000. Charles Schwab Investment Management Inc. lifted its position in shares of Option Care Health by 6.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after acquiring an additional 147,054 shares during the period. Global Alpha Capital Management Ltd. lifted its position in shares of Option Care Health by 38.1% during the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after acquiring an additional 18,992 shares during the period. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Option Care Health during the 4th quarter worth $327,000. Institutional investors own 98.05% of the company's stock.
Insider Buying and Selling at Option Care Health
In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.64% of the company's stock.
Option Care Health Price Performance
Shares of NASDAQ:OPCH traded up $0.07 during trading on Monday, reaching $32.97. The company had a trading volume of 2,800,639 shares, compared to its average volume of 1,780,957. The stock has a market capitalization of $5.42 billion, a P/E ratio of 27.71, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a fifty day moving average of $33.36 and a two-hundred day moving average of $28.76.
Wall Street Analysts Forecast Growth
OPCH has been the subject of several recent analyst reports. Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Monday, April 21st. JMP Securities restated a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a research report on Tuesday, April 22nd. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. increased their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Finally, Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and an average target price of $33.75.
Check Out Our Latest Stock Report on OPCH
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
